MoonLake Immunotherapeutics
MLTX
#6430
Rank
NZ$1.64 B
Marketcap
NZ$19.28
Share price
2.27%
Change (1 day)
17.64%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2026 (TTM): -NZ$0.45 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.4 Billion a decrease over its 2024 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.45 Billion11.34%
2025 -NZ$0.4 Billion79.14%
2024 -NZ$0.23 Billion129.45%
2023 -NZ$96.45 Million-16.81%
2022 -NZ$0.12 Billion